These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17694067)

  • 1. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
    Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
    Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
    Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
    J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.
    Küçük C; Hu X; Iqbal J; Gaulard P; Klinkebiel D; Cornish A; Dave BJ; Chan WC
    Am J Pathol; 2013 Jan; 182(1):49-55. PubMed ID: 23142381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
    Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
    Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
    Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
    Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HACE1 is a potential tumor suppressor in osteosarcoma.
    El-Naggar AM; Clarkson PW; Negri GL; Turgu B; Zhang F; Anglesio MS; Sorensen PH
    Cell Death Dis; 2019 Jan; 10(1):21. PubMed ID: 30622235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
    Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
    Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
    Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
    Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.
    Goka ET; Lippman ME
    Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes.
    Turgu B; El-Naggar A; Kogler M; Tortola L; Zhang HF; Hassan M; Lizardo MM; Kung SH; Lam W; Penninger JM; Sorensen PH
    EMBO Rep; 2023 Dec; 24(12):e56815. PubMed ID: 37846480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.
    El-Hachem N; Habel N; Naiken T; Bzioueche H; Cheli Y; Beranger GE; Jaune E; Rouaud F; Nottet N; Reinier F; Gaudel C; Colosetti P; Bertolotto C; Ballotti R
    Cell Death Differ; 2018 Nov; 25(11):2010-2022. PubMed ID: 29515254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases.
    Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
    Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate.
    Tortola L; Nitsch R; Bertrand MJM; Kogler M; Redouane Y; Kozieradzki I; Uribesalgo I; Fennell LM; Daugaard M; Klug H; Wirnsberger G; Wimmer R; Perlot T; Sarao R; Rao S; Hanada T; Takahashi N; Kernbauer E; Demiröz D; Lang M; Superti-Furga G; Decker T; Pichler A; Ikeda F; Kroemer G; Vandenabeele P; Sorensen PH; Penninger JM
    Cell Rep; 2016 May; 15(7):1481-1492. PubMed ID: 27160902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction.
    Cetinbas N; Daugaard M; Mullen AR; Hajee S; Rotblat B; Lopez A; Li A; DeBerardinis RJ; Sorensen PH
    Oncogene; 2015 Jul; 34(30):4005-10. PubMed ID: 25284589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between HACE1 Gene Polymorphisms and Wilms' Tumor Risk in a Chinese Population.
    Jia W; Deng Z; Zhu J; Fu W; Zhu S; Zhang LY; Hu J; Wang F; Xia H; Liu GC; He J
    Cancer Invest; 2017 Nov; 35(10):633-638. PubMed ID: 29243987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.
    Zhang L; Chen X; Sharma P; Moon M; Sheftel AD; Dawood F; Nghiem MP; Wu J; Li RK; Gramolini AO; Sorensen PH; Penninger JM; Brumell JH; Liu PP
    Nat Commun; 2014 Mar; 5():3430. PubMed ID: 24614889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HACE1, an E3 Ubiquitin Protein Ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus Infection-Induced Oxidative Stress by Promoting Nrf2 Activity.
    Kumar B; Roy A; Asha K; Sharma-Walia N; Ansari MA; Chandran B
    J Virol; 2019 May; 93(9):. PubMed ID: 30787155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2QL1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene.
    Wake NC; Ricketts CJ; Morris MR; Prigmore E; Gribble SM; Skytte AB; Brown M; Clarke N; Banks RE; Hodgson S; Turnell AS; Maher ER; Woodward ER
    Hum Mutat; 2013 Dec; 34(12):1650-61. PubMed ID: 24000165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.